Precigen Inc
NASDAQ:PGEN

Watchlist Manager
Precigen Inc Logo
Precigen Inc
NASDAQ:PGEN
Watchlist
Price: 3.62 USD 3.13% Market Closed
Market Cap: 1.3B USD

During the last 3 months Precigen Inc insiders bought 68.3k USD , and sold 37.5m USD worth of shares. The stock price has increased by 1% over this period (open performance analysis).

The last transaction was made on Nov 21, 2025 by Kirk Randal J , who sold 3.6m USD worth of PGEN shares.

Last Transactions:
Kirk Randal J
$-3.6m
Kirk Randal J
Vice President, Finance
$-3.8m
Kirk Randal J
Vice President, Finance
$-4.9m
Kirk Randal J
$-6.2m
Kindler Jeffrey B
$-361.1k
Tennant Phil
$+21.5k
Thomasian Harry Jr.
$+10k
Shah Rutul R
$+6.8k
Thomasian Harry Jr.
$+30k
Kirk Randal J
$-13.2m
Kirk Randal J
$-5.4m
Agee Nancy H
$+69k
Agee Nancy H
$+49.5k
Agee Nancy H
$+49.2k
Kirk Randal J
$+20m
Perez Jeffrey Thomas
$+50k
Kirk Randal J
$+136.3k
Kindler Jeffrey B
$-136.3k
Mitchell Dean J
$+35.3k
Sabzevari Helen
$-117.8k
Thomasian Harry Jr.
$-14.8k
Lehr Donald P.
$-18k
Shah Rutul R
$-8.8k
Perez Jeffrey Thomas
$-14.6k
Sabzevari Helen
$-92.7k
Perez Jeffrey Thomas
$-13.5k
Thomasian Harry Jr.
$-13.8k
Lehr Donald P.
$-16.7k
Shah Rutul R
$-8.2k
Kirk Randal J
$+180.3k
Kirk Randal J
$+150k
Frank Steven
$+688k
View All Transactions

During the last 3 months Precigen Inc insiders bought 68.3k USD , and sold 37.5m USD worth of shares. The stock price has increased by 1% over this period (open performance analysis).

The last transaction was made on Nov 21, 2025 by Kirk Randal J , who sold 3.6m USD worth of PGEN shares.

Sold
0-3
months
37.5m USD
2
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
3
68.3k USD
3-6
months
1
167.6k USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Precigen Inc
Insider Trading Chart

Precigen Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Precigen Inc
Last Insider Transactions

Global
Insiders Monitor

Precigen Inc
Glance View

Market Cap
1.3B USD
Industry
Biotechnology

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. The company is headquartered in Germantown, Maryland and currently employs 456 full-time employees. The company went IPO on 2013-08-08. Its therapeutic platforms, including UltraCAR-T, AdenoVerse immunotherapy, and ActoBiotics, are designed to precisely control the level and physiological location of gene expression and modify biological molecules to control the function and output of living cells to treat underlying disease conditions. The Company’s lead clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. The firm also completed a Phase I study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform. The company also has a robust pipeline of preclinical programs.

PGEN Intrinsic Value
HIDDEN
Show

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top